Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $12.3 million.

  • NeuroPace's Accumulated Expenses rose 2228.95% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 2228.95%. This contributed to the annual value of $9.8 million for FY2024, which is 1245.97% down from last year.
  • As of Q3 2025, NeuroPace's Accumulated Expenses stood at $12.3 million, which was up 2228.95% from $9.7 million recorded in Q2 2025.
  • NeuroPace's 5-year Accumulated Expenses high stood at $12.3 million for Q3 2025, and its period low was $5.7 million during Q1 2021.
  • In the last 5 years, NeuroPace's Accumulated Expenses had a median value of $7.7 million in 2024 and averaged $8.3 million.
  • In the last 5 years, NeuroPace's Accumulated Expenses soared by 5079.58% in 2023 and then tumbled by 1245.97% in 2024.
  • Over the past 5 years, NeuroPace's Accumulated Expenses (Quarter) stood at $7.9 million in 2021, then decreased by 6.42% to $7.4 million in 2022, then surged by 50.8% to $11.2 million in 2023, then dropped by 12.46% to $9.8 million in 2024, then rose by 25.85% to $12.3 million in 2025.
  • Its Accumulated Expenses was $12.3 million in Q3 2025, compared to $9.7 million in Q2 2025 and $8.1 million in Q1 2025.